bibliography - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/8380/16/16...kansasii or...

Chapter - 7

Bibliography

Reference / Bibliography

168

1. Abba AA, Bamgboye AE, Afzal M, Rahmatullah RA.

Lymphadenopathy in adults. A clinico-pathological analysis.

Saudi Med J 2002; 23: 282-286.

2. Adkins MS, Raccuia JS, Acinapura AJ. Esophageal perforation

in a patient with acquired immunodeficiency syndrome. Ann

Thorac Surg 1990; 50: 299-300.

3. Aggarwal P, Wali JP, Singh S, Handa R, Wig N, Biswas A. A

clinico-bacteriological study of peripheral tuberculous

lymphadenitis. J Assoc Physicians India 2001; 49: 808-812.

4. Agudo JM, Castrillo JM. Lymphadenitis as a characteristic

manifestation of disseminated tuberculosis in intravenous drug

abusers infected with human immunodeficiency virus. J Infect

1987; 14: 191-193.

5. Ahn, C. H., J. R. Lowell, S. S. Ahn, S. Ahn, and G. A. Hurst.

Chemotherapy for pulmonary disease due to Mycobacterium

kansasii: efficacies of some individual drugs. Rev. Infect. Dis.

1981;3:1028–1034.

6. Ahn, C. H., D. R. Nash, and G. A. Hurst. Ventilatory defects in

atypical mycobacteriosis. Am. Rev. Respir. Dis. 1976;113:273–

279.

7. Ahn CH, McLatty JW, AHN SS, et al. Diagnostic criteria for

pulmonary disease caused by Mycobacterium kansasii and


169

Mycobacterium intracellulare. Am Rev Respir dis 1982;125:

388-391.

8. Ahn, C. H., J. R. Lowell, G. D. Onstad, E. H. Shuford, and G. A.

Hurst. A demographic study of disease due to Mycobacterium

kansasii or M.intracellulare-avium in Texas. Chest 1979;75:120–

125.

9. Allerberger F. An outbreak of suppurative lymphadenitis

connected with BCG vaccination in Austria, 1990 (1991)

[Letter]. Am Rev Respir Dis 1991; 144: 469.

10. AIIMS-WHO Meeting on the Involvement of Medical Schools in T

and STI/HIV Control. Report of an Informal Consultation on 28-

30 November 2001 and Follow-up meeting on 29 April 2002.

New Delhi: All India Institute of Medical Sciences - World Health

Organization (SEARO); 2002.

11. Aitken, M. L., W. Burke, G. McDonald, D. Wallis, B. Ramsey,

and G. Nolan. Nontuberculous mycobacterial disease in adult

cystic fibrosis patients. Chest 1993;103:1096–1099.

12. AK Chakraborty. Epidemiology of tuberculosis: current status in

India. Indian J Med Res 2004;120:248-276.

13. Alvarez S, MeCabe WR. Extra pulmonary tuberculosis revisited:

a review of experience at Boston city and other hospitals.

Medicine 1984; 63: 25–53.


170

14. American Trudeau Society, (1954). American Review of

Tuberculosis, 70, 949.

15. Antonucci G, Girardi E, Armignacco O, Salmaso S, Ippolito G.

Tuberculosis in HIV-infected subjects in Italy: a multicentre

study. The Gruppo Italiano di Studio Tubercolosi e AIDS. AIDS

1992; 6: 1007-1013.

16. Anuradha B, Aparna S, Priya VH, Lakshmi VV, Akbar Y, , Latha

GS, Murthy KJR. Prevalence of drug resistance under the DOTS

strategy in Hyderabad, South India, 2001-2003. Int J Tuberc

Lung Dis 2006; 10: 58-62. Erratum in: Int J Tuberc Lung Dis.

2006 Jun;10 (6):708.

17. Appling D, Miller HR. Mycobacterial cervical lymphadenopathy:

1981 update. Laryngoscope 1981; 91: 1259-1266.

18. Arora VK, Gupta R. Trends of extra-pulmonary tuberculosis

under revised National Tuberculosis Control Program: A study

from South Delhi. Indian J Tuberc 2006; 53: 77-83.

19. Bancroft JD and Stevens A : Theory and pratice of histological

techniques 4th edition.Churchill livingstone,1996.

20. Bailey, R. K., S. Wyles, M. Dingley, F. Hesse, and G. W. Kent.

The isolation of high catalase Mycobacterium kansasii from tap

water. Am. Rev. Respir. Dis. 1970;101:430–431.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Anuradha+B%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Aparna+S%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Priya+VH%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Lakshmi+VV%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Akbar+Y%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Latha+GS%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Latha+GS%22%5BAuthor%5D

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Search&itool=pubmed_Abstract&term=%22Murthy+KJ%22%5BAuthor%5D


171

21. Bailey, W. C., M. Brown, H. A. Buechner, H. Weill, H. Ichinose,

and M. Ziskind. Silicomycobacterial disease in sandblasters.

Am. Rev. Respir. Dis.1974;110:115–125.

22. Barnes PF, Barrows SA. Tuberculosis in the 1990s. Ann Intern

Med 1993;119: 400-410.

23. Beerwerth, W. Mykobakterien in viehtra¨nken und ober

fla¨chengewa¨ssern. Dtsch. Tieraerztl. Wochenschr.1973;

80:398–401.

24. Bem C. Human immunodeficiency virus-positive tuberculous

lymphadenitis in Central Africa: clinical presentation of 157

cases. Int J Tuberc Lung Dis 1997; 1: 215-219

25. Bem C, Patil PS, Elliott AM, et al. The value of wide-needle

aspiration in the diagnosis of tuberculous lymphadenitis in

Africa. AIDS 1993;7:1221-1225.

26. Ben Salah I, Cayrou c, Raoult D, Drancourt M. Mycobacterium

marseillnese sp.nov., Mycobacterium timonense sp. nov., and

Mycobacterium bouchedurhonense sp.nov., members of the

Mycobacterium avium complex. Int J Syst Evol Microbiol.

2009;59:2803-8.

27. Beutler B, Cerami A. The common mediator of shock, cachexia,

and tumor necrosis. Adv Immunol 1988; 42: 213-231.

28. Black, B.C. and Chapman, J.S .Paediatrics.1964;33: 887.


172

29. Boxerbaum, B. Isolation of rapidly growing mycobacteria in

patients with cystic fibrosis. J. Pediatr.1980;96:689–691.

30. Boyd, W. 1944. Pathology of Internal Diseases, London.

31. Breathnach, A., N. Levell, C. Munro, S. Natarajan, and S.

Pedler. Cutaneous Mycobacterium kansasii infection: case report

and review. Clin. Infect. Dis. 1995;20:812–817.

32. Brown, B. A., R. J. Wallace, Jr., G. O. Onyi, V. De Rosas, and R.

J. Wallace, III. Activities of four macrolides, including

clarithromycin, against Mycobacterium fortuitum, Mycobacterium

chelonae, and M. chelonae-like organisms. Antimicrob. Agents

Chemother. 1992;36:180–184.

33. Burback, B. L., and J. J. Perry. Biodegradation and

biotransformation of groundwater pollutant mixtures by

Mycobacterium vaccae. Appl. Environ. Microbiol. 1993;

59:1025–1029.

34. Burback, B. L., J. J. Perry, and L. E. Rudd. Effect of

environmental pollutants and their metabolites on a soil

mycobacterium. Appl. Microbiol. Biotechnol. 1994;41:134–136.

35. Cadre D V, Singh U R, Talwar V. Diagnosis of tubercular

cervical lymphadenitis by FNAC, microscopy and culture. Indian

J Tuberc 1991; 38: 25-7.


173

36. Campbell LA, Dyson IA. Lymph nodes tuberculosis a

comparision of treatments 18 months after completion of

chemotherapy. Tubercle 1979; 60: 95-98.

37. Cangelosi, G. A., C. O. Palermo, J. P. Laurent, A. M. Hamlin,

and W. H. Brabant. Colony morphotypes on Congo red agar

segregate along species and drug susceptibility lines in the.

Mycobacterium avium-intracellulare complex. Microbiology.

1999; 145:1317–1324.

38. Cantrell R, Jensen JH, Reid D. Diagnosis and management of

tuberculous cervical adenitis. Arch Otolaryngol 1975; 101: 53-

57.

39. Castro JD, Hoover L, Castro DJ, et al. Cervical mycobacterial

lymphadenitis. Arch Otolaryngol 1985; 111:816-819.

40. Carson, L. A., N. J. Petersen, M. S. Favero, and S. M. Aguero.

Growth characteristics of atypical mycobacteria in water and

their comparative resistance to disinfectants. Appl. Environ.

Microbiol. 1978;36:839–846.

41. Central TB Division (CTD), Directorate General of Health

Services, Ministry of Health and Family, Welfare, Government of

India. Revisied National Tuberculosis Control Programme

(RNTCP), Technical and operational guidelines for Tuberculosis

Control, Nirman Bhavan, New Delhi. CTD. 2005.

www.tbcindia.org

http://www.tbcindia.org/


174

42. Chakrabarti A, Sharma M, Dubey ML. Isolation rates of different

mycobacterial species from Chandigarh (north India). Indian J

Med Res 1990; 91: 111-4.

43. Chen YM, Lee PY, Su WJ, Perng RP. Lymph node tuberculosis:

7-year experience in Veterans General Hospital, Taipei, Taiwan.

Tuber Lung Dis 1992; 73: 368-371.

44. Chitra C, Saicharan, Prasad CE, KJR Murthy. Spectrum of drug

resistance in patients referred during 1998-2002 in Hyderabad,

India. Int J Tuberc Lung Dis,2003 ;7,11,2;301.

45. Choudhri, S., J. Manfreda, J. Wolfe, S. Parker, and R. Long.

Clinical significance of nontuberculous mycobacteria isolates in

a Canadian tertiary care center. Clin. Infect. Dis. 1995; 21:128–

133.

46. Christianson LC, Dewlett HJ. Pulmonary disease in adults

associated with unclassified mycobacteria. Am J Med

1960;29:980-91.

47. Collins, C. H., and M. D. Yates. Infection and colonisation by

Mycobacterium kansasii and Mycobacterium xenopi: aerosols as

a possible source? J. Infect. 1984; 8:178–179.

48. Clegg, H. W., M. T. Foster, W. E. Sander, Jr., and W. B. Baine.

Infection due to organisms of the Mycobacterium fortuitum

complex after augmentation mammaplasty: clinical and

epidemiologic features. J. Infect. Dis.1983; 147:427–433.


175

49. Coleman, J. P., and J. J. Perry. Fate of the C1 product of

propane dissimilation in Mycobacterium vaccae. J.

Bacteriol.1984;160:1163–1164.

50. Collins, C. H., J. M. Grange, and M. D. Yates. A review:

mycobacteria in water. J. Appl. Bacteriol. 1984;57:193–211.

51. Colville, A. Retrospective review of culture-positive

mycobacterial lymphadenitis cases in children in Nottingham,

1979–1990. Eur. J. Clin. Microbiol. Infect. Dis.1993;12:192–

195.

52. Comstock GW, Edwards LB, Livesay VT. Tuberculosis morbidity

in the US Navy: its distribution and decline. Am Rev Respir Dis

1974; 110: 571-580.

53. Contreras, M. A., O. T. Cheung, D. E. Sanders, and R. S.

Goldstein. Pulmonary infection with nontuberculous

mycobacteria. Am. Rev. Respir. Dis. 1988;137:149–152.

54. Cooper, A. M., R. Appelberg, and I. M. Orme.

Immunopathogenesis of. Mycobacterium avium infection. Front.

Biosci. 1998;3:141–148.

55. Cooper, J. F., M. J. Lichtensein, B. S. Graham, and W.

Schaffner. Mycobacterium chelonae: a cause of nodular skin

lesions with a proclivity for renal transplant recipients. Am. J.

Med. 1989;86:173–177.


176

56. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG,

Raviglione MC, et al. The growing burden of tuberculosis: global

trends and interactions with the HIV epidemic. Arch Intern Med

2003; 163: 1009-21.

57. Corner, L. A., R. H. Barrett, A. W. D. Lepper, V. Lewis, and C.

W. Pearson. A survey of mycobacteriosis of feral pigs in the

northern territory. Aust. Vet. J. 1981; 57:537–542.

58. Crow HE, King CT, Smith E. A limited clinical, pathologic, and

epidemiologic study of patients with pulmonary lesions

associated with atypical acid-fast bacilli in the sputum. Am Rev

Tuberc 1957;75:199-222.

59. CTD. Revised National TB Control Programme. Technical

guidelines for TB control. New Delhi.CTD, 1997.

60. CTD. Managing the Revised National TB Control Program in

your area. A training course modules 1-4 and 4-8. New

Delhi.CTD. 1998.

61. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA,

Jacobs WR Jr, et al. An outbreak of tuberculosis with

accelerated progression among persons infected with the human

immunodeficiency virus: an analysis using restriction fragment

length polymorphisms. N Engl J Med 1992; 326: 231-5.

62. Dale, J. W. Mobile genetic elements in mycobacteria. Eur Respir

J. Suppl. 1995; 20:633s–648s.


177

63. Dalovisio, J. R., G. A. Pankey, R. J. Wallace, and D. B. Jones.

Clinical usefulness of amikacin and doxycycline in the

treatment of infection due to Mycobacterium fortuitum and

Mycobacterium chelonei. Rev. Infect. Dis. 1981; 3:1068–1074.

64. Dandapat MC. Mishra BM, Dash SP, Kar PK. Peripheral lymph

node tuberculosis: a review of 80 cases. Br J Surg 1990; 77:

911-912.

65. Dandapat MC, Patra BK. Diagnosis of tubercular lymphadenitis

by fine needle aspiration cytology. Indian J Tuberc 1987; 34:

139-142.

66. Daniel P. O’Brien, Bart J. Curie, Vicki L. Krause. Non

tuberculous mycobacterial disease in northern Australia: A case

series and review of the literature. Clin Infect Dis 2000; 31: 958-

968.

67. Dawson, D. J., M. Reznikov, Z. M. Blacklock, and J. H. Leggo.

Atypical mycobacteria isolated from clinical material in south-

eastern Queensland. Pathology. 1974; 6:153–160.

68. Dawson, D. J. Mycobacterial terminology. J. Clin. Microbiol.

2000;38:3913.

69. Debrunner, M., M. Salfinger, O. Bra¨ndli, and A. von Graevenitz.

Epidemiology and clinical significance of nontuberculous

mycobacteria in patients negative for human immunodeficiency

virus in Switzerland. Clin.Infect. Dis. 1992;15:330–345.


178

70. De Groote MA, Pace NR, Fulton K, Falkinham JO III.

Relationships between Mycobacterium isolates from patients

with pulmonary mycobacterial infections and potting soils. Appl

Environ Microbiol.2006;72:7602-6.

71. Deitel M, Saldanha CF, Borowy JZ. Treatment to tuberculous

masses in the neck. Can J Surg 1984;27:90-93.

72. Department for Public Health. Reported cases of certain

notifiable diseases. San Francisco Epidemio Bull 1989;5:4.

73. Ding LW, Lai CC, Lee LN, Hsueh PR. Disease caused by non-

tuberculous mycobacteria in a university hospital in Taiwan,

1997-2003. Epidemiol Infect.2006;134:1060-7.

74. Doctor, H.G. Indian Journal of Medical Sciences.1964;18: 411.

75. Domenech, P., M. C. Menendez, and M. J. Garcia. Restriction

fragment length polymorphisms of 16S rRNA genes in the

differentiation of fast-growing mycobacterial species. FEMS

Microbiol. Lett. 1994;116:19–24.

76. Dunn, B. L., and D. J. Hodgson. ‘Atypical’ mycobacteria in milk.

J. Appl. Bacteriol. 1982;52:373–376.

77. Dutt AK, Stead WW. Epidemiology. In: Schlossberg D,

editor.Tuberculois and nontuberculous mycobacterial infection.

Philadelphia: W.B. Saunders Company; 1999; p. 3-16.


179

78. Duvall CW. Studies in atypical forms of tubercle bacilli isolated

directly from the human tissues in cases of primary cervical

adenitis. J Exp Med 1908; 9: 403-29.

79. Eaton, T., J. O. Falkinham 3rd, and C. F. von Reyn. Recovery of

Mycobacterium avium from cigarettes. J. Clin. Microbiol.1995;

33:2757–2758.

80. Edwards LB, Acqaviv FA. An atlas of sensitivity to tuberculin,

PPD-B and histoplasmin the United States, Am Rev Respir Dis,

1969; 99, Suppl.: 1-131.

81. Edwards, M. L., J. M. Goodrich, D. Muller, A. Pollack, J. E.

Zeigler, and D. W. Smith. Infection with Mycobacterium avium-

intracellulare and the protective effects of Bacille Calmette-

Gue´rin. J. Infect. Dis. 1982;145:733–741.

82. Efthimiou, J., M. J. Smith, M. E. Hodson, and J. C. Batten.

Fatal pulmonary infection with Mycobacterium fortuitum in

cystic fibrosis. Br. J. Dis. Chest.1984;78:299–302.

83. Enarson DA, Ashley MJ, Grzybowski S. Non respiratory

tuberculosis in Canada: epidemiologic and bacteriologic

features. Am J Epidemiol 1980; 112: 341-351.

84. Engel, H. W. B., L. G. Berwald, and A. H. Havelaar. The

occurrence of Mycobacterium kansasii in tap water. Tubercle.

1980; 61:21–26.


180

85. Engel, H. W. B., L. G. Berwald, B. W. Lindeboom, and A. H.

Havelaar. Mycobacterium kansasii infections in the Netherlands:

a brief summary.Rev. Infect. Dis. 1981; 3:1024.

86. Euzeby JP 2003. List of bacterial names with - standing in

nomenclature - Genus Mycobacterium.

http://www.bacterio.cict.fr/m/mycobacterium. html.

87. Fain O, Lortholary O, Djouab M, Amoura I, Bainet P, Beaudreuil

J, et al. Lymph node tuberculosis in the suburbs of Paris: 59

cases in adults not infected by the human immunodeficiency

virus. Int J Tuberc Lung Dis 1999; 3 : 162-5.

88. Falkinham JO III. Epidemiology of infections by nontuberculous

mycobacteria. Clin Microbiol Rev 1996; 9: 177-215.

89. Falkinham JO III, Iseman MD, De Haas P, van Soolingen D.

Mycobaterium avium in a shower linked to pulmonary disease.

J Water Health. 2008;6:209-13.

90. Falkinham JO III. Surrounded by mycobacteria: non

tuberculous mycobacteria in the human environment. J Appl

Microbiol. 2009;107:356-67.

91. Fanning A. Tuberculosis: 6. Extrapulmonary disease. CMAJ

1999; 160: 1597-603.

92. Feldman PS, Kaplan MJ, Johns ME. Fine needle aspiration in

squamous cell carcinoma of the head and neck. Arch

Otolaryngol 1983;109:735-742.

http://www.bacterio.cict.fr/m/mycobacterium.%20html


181

93. Farer LS, Lowell AM, Meador MP. Extrapulmonary tuberculosis

in the United states. Am. J Epidemiol 1979;109:205-217.

94. Feazel LM, Baumgartner LK, Peterson KL, Frank DN, Haris JK,

Pace NR. Opportunistic pathogens enriched in showerhead

biofilms. Proc Natl Acad Sci U S A. 2009;106:16393-9.

95. Finfer M, Perchick A, Burstein DE. Fine needle aspiration

biopsy diagnosis of tuberculous lymphadenitis in patients with

and without the acquired immuno deficiency syndrome. Acta

Cytol 1991;35:325-332.

96. Fischeder, R., R. Schulze-Ro¨bbecke, and A. Weber. Occurrence

of mycobacteria in drinking water samples. Zentralbl. Hyg.

Umweltmed. 1991;192: 154–158.

97. Fitzgerald, D. A., A. G. Smith, A. Lees, L. Yee, N. Cooper, S. C.

Harris, and J. A. Gibson. Cutaneous infection with

Mycobacterium abscessus. Br. J. Dermatol. 1995;132:800–804.

98. Fraser Wares, Balasubramanian R, Mohan A, Sharma S

K.(2005) Extrapulmonary Tuberculosis: Management and

Control. www.tbcindia.org/documentation/publication.

99. Gaynor, W. T., D. V. Cousins, and J. A. Friend. Mycobacterial

infection in numbats (Myrmecobius fasciatus). J. Zoo Wildl. Med.

1990; 21:476–479.


182

100. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten DK.

Assessment of lymph node tuberculosis in northern Germany: a

clinical review. Chest 2002; 121: 1177-1182.

101. German, J.L., Black, T.C. and Chapman, J.H. (1956). Diseases

of Chest.1956; 30: 326.

102. Global Tuberculosis Control. WHO report 2012:Geneva. World

Health Organization 2012:

(http://www.WHO.Int/tb/publication/global-report/2012/)

103. Griffith DE, Aksamit T, Brown-Elliot BA, Catanzaro A, Daley C,

Gordin F. An official ATS/IDSA statement: diagnosis, treatment

and prevention of non-tuberculous mycobacterial diseases. Am

J Respir Crit Care Med. 2007;175:367-416

104. Griffith, D. E., W. M. Girard, and R. J. Wallace, Jr. Clinical

features of pulmonary disease caused by rapidly growing

mycobacteria: an analysis of 154 patients. Am. Rev. Respir. Dis.

1993;147:1271–1278.

105. Good RC. Opportunistic pathogens in the genus

Mycobacterium, Ann Rev Microbiol, 1985; 39: 347-69.

106. Good, R. C. Isolation of nontuberculous mycobacteria in the

United States, 1979. J. Infect. Dis. 1980;142:779–783

107. Good, R. C., and D. E. Snider, Jr. Isolation of nontuberculous

mycobacteria in the United States, 1980. J. Infect. Dis. 1982;

146:829–833.

http://www.who.int/tb/publication/global-report/2012/


183

108. Goslee, S., and E. Wolinsky. Water as a source of potentially

pathogenic mycobacteria. Am. Rev. Respir. Dis. 1976; 113:287–

292.

109. Grange JM, Collins CH. Mycobacterial pathogenicity and

nomenclature: the ‘nyrocine mycobacteria’ [letter],Tubercle. ,

1983; 64: 141-2.

110. Gorse, G. J., R. D. Fairshter, G. Friedly, L. Dela Maza, G. R.

Greene, and T. C. Cesario. Nontuberculous mycobacterial

disease. Experience in a southern California hospital. Arch.

Intern. Med. 1983;143:225–228.

111. Gupta SP, Arora A, Bhargava DK. An unusual presentation of

oesophageal tuberculosis. Tuber Lung Dis 1992; 73: 174-176.

112. Gupta SK, Chugh TD, Sheikh ZA. Cytodiagnosis of tuberculous

lymphadenitis: a correlative study with microbiologic

examination. Acta Cytol 1993; 37: 329-332.

113. Gupta AK, Nayar M, Chandra M. Critical appraisal of fine needle

aspiration cytology in tuberculous lymphadenitis. Acta Cytol

1992; 36: 391-394.

114. Haas DW, Des Prez RM. Tuberculosis and acquired

immunodeficiency syndrome: a historical perspective on recent

developments. Am J Med 1994; 96 : 439-50.


184

115. Haas, C. N., M. A. Meyer, and M. S. Paller. The ecology of acid-

fast organisms in water supply, treatment, and distribution

systems. Am. Water Works Assoc. J.1983;75:139–144.

116. Hansen GA. Bacillus Leprae, Virchows Archiv.1880;79:32-42.

117. Hardas UD, Jayaram VS. Differential identification of

mycobacteria. Indian J Tuberc 1984; 31: 11-13.

118. Havlir DV, Barnes PF. Tuberculosis in patients with human

immunodeficiency virus infection. N Engl J Med 1999; 340:

367-73.

119. Hein, W. R., and A. A. Tomasovic. 1981. An abattoir survey of

tuberculosis in feral buffaloes. Aust. Vet. J. 57:543–547.

120. Henry MT, Inamdar L, Riordain DO, Schweiger M, Watson JP.

Non tuberculous mycobacteria in non-HIV patients:

epidemiology, treatment and response. Eur Respir J 2004; 23:

741-6.

121. Henry M Marshall, Robyn Carter, Matthew J.Torbey, Sharri

Minion, Carla Tolson, Hanna E.Sidjabat, Flavia Huygens, Megan

Hargreaves, Rachel M. Thomson. Mycobacterium lentiflavum in

drinking water supplies, Australia. EID.2011;17:395-402.

122. Heurlin, N., and B. Petrini. Treatment of non-tuberculous

mycobacterial infections in patients without AIDS. Scand. J.

Infect. Dis.1993; 25:619–623.


185

123. Hinden, E., Nardell, S.G. and Anabtawi, S. Tubercle. 1952; 32:

2.

124. Hooper AA. Tuberculous peripheral lymphadenitis. Br J Surg

1972; 59: 353-359.

125. Horsburgh, C. R., Jr. Mycobacterium avium complex infection

in the acquired immunodeficiency syndrome. N. Engl. J. Med.

1991;324:1332–1338.

126. Horsburgh, C. R., Jr. Epidemiology of mycobacterial diseases in

AIDS. Res. Microbiol. 1992;143:372–377.

127. Horsburgh, C. R., Jr., and R. Selik. The epidemiology of

disseminated nontuberculous mycobacterial infection in the

acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir.

Dis. 1989;139:4–7.

128. Huang, Z. H., B. C. Ross, and B. Dwyer. Identification of

Mycobacterium kansasii by DNA hybridization. J. Clin.

Microbiol. 1991; 29:2125–2129.

129. Hudgins, A.P. Medical Times.1943; 51, 75.

130. http://www.tbcindia.org/pdfs/Tuberculosis Control in India.pdf

131. Im JG, Kim JH, Han MC. Computed tomography of

esophageomediastinal fistula in tuberculous mediastinal

lymphadenitis. J Comput Assit Tomogr 1990;14:89-92.

http://www.tbcindia.org/pdfs/Tuberculosis%20Control%20in%20India.pdf


186

132. Ingram, C. W., D. C. Tanner, D. T. Durack, G. W. Kernodle, Jr.,

and G. R. Corey. Disseminated infection with rapidly growing

mycobacteria.Clin. Infect. Dis. 1993;16:463–471.

133. International Union against Tuberculosis and Lung Diseases

(IUATLD): Minimum Requirements, Role And Operation In A

Low Income Country. The Public Health Service National

Tuberculosis Reference Laboratory and the National Laboratory

Network.1998: 62- 65

134. Iscman MD. Tuberculosis in relation to human

immunodeficiency virus and acquired immunodeficiency

syndrome. In: Iseman MD, editor. A clinician’s guide to

tuberculosis. Philadelphia: Lippincott Williams and Wilkins;

2000 p. 199-252.

135. Isaac-Renton, J. L., E. A. Allen, C.-W. Chao, S. Grzybowski, E. I.

Whittaker, and W. A. Black. Isolation and geographic

distribution of Mycobacterium other than M. tuberculosis in

British Columbia, 1972–1981. Can. Med. Assoc. J.

1985;133:573–576.

136. Iseman MD, Marras TK. The importance of Non-tuberculous

mycobacterial lung disease. Am J Respir Crit Care Med.

2008;178:999-1000.


187

137. Jesudason MV, Gladstone P. Non tuberculous mycobacterial

isolated from clinical specimens at a tertiary care hospital in

south India. Indian J Med Microbiol 2005; 23(3): 172-5.

138. Jenkins, P. A. The epidemiology of opportunist mycobacterial

infections in Wales, 1952–1978. Rev. Infect. Dis. 1981; 3:1021–

1023.

139. Jenkins, P. A., S. R. Pattyn, and F. Portaels. Diagnostic

bacteriology, p. 441–470. In C. Rattledge and J. Stanford (ed.),

The biology of the mycobacteria, vol. 1. Academic Press Ltd.,

1982. London.

140. Jha BC, Dass A, Nagarkar NM. Cervical tuberculous

lymphadenopathy: Changing clinical pattern and concepts in

management . Postgrad Med J 2001;77:185-187.

141. Johanson, W. G., Jr., and D. P. Nicholson. Pulmonary disease

due to Mycobacterium kansasii: an analysis of some factors

influencing prognosis. Am. Rev. Respir. Dis. 1969;99:73–85.

142. Jones PG, Campbell PE. Tuberculous lymphadenitis in

childhood: The significance of anonymous mycobacteria. Br J

Surg 1962; 50 : 302-314.

143. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F,

Barnes PF. Relationship of the manifestations of tuberculosis to

CD4 cell counts in patients with human immunodeficiency virus


188

infection. Am Rev Respir

Dis 1993; 148 : 1292-1297.

144. Jones, R. J., and D. E. Jenkins. Mycobacteria isolated from soil.

Can.J. Microbiol. 1965; 11:127–133.

145. Jones, B.S, (1951). British Medical Journal, 1.1056.

146. Joynson, D. H. M. Water: the natural habitat of Mycobacterium

kansasii. Tubercle. 1979; 60:77–81.

147. Karak K, Bhattacharyya S, Majumdar S, De PK. Pulmonary

infections caused by mycobacteria other than M tuberculosis in

and around Calcutta. Indian J Pathol Microbiol 1996; 39: 131-4.

148. Katoch VM. Infections due to non tuberculous mycobacteria

(NTM). Indian J Med Res 2004; 120: 290-304.

149. Katoch VM, Mohan Kumar T . Atypical mycobacterial infections.

In: Sharma SK, editor. Tuberculosis, 1st ed. New Delhi: Jaypee

Brothers Medical Publishers (P) Ltd; 2001 p. 439-451.

150. Kaustova, J., Z. Olsovsky, M. Kubin, O. Zatloukal, M. Pelikan,

and Y. Hradil. Endemic occurrence of Mycobacterium kansasii in

water supply systems. J. Hyg. Epidemiol. Microbiol. Immunol.

1981;25:24–30.

151. Kazda, J., K. Mu¨ller, and L. M. Irgens. Cultivable mycobacteria

in sphagnum vegetation of moors in south Sweden and coastal

Norway. Acta Pathol. Microbiol. Scand. Sect. B 1979;87:97–101.


189

152. Kent DC., Tuberculous lymphadenitis: not a localized disease

process. Am J Med Sci 1967;254:866-874.

153. Kheiry J, Ahmed ME, Cervical lymphadenopathy in Khartoum. J

Trop Med Hyg 1992; 95:416-419.

154. Kilby, J. M., P. H. Gilligan, J. R. Yankaskas, W. E. Highsmith,

Jr., L. J. Edwards, and M. R. Knowles. Nontuberculous

mycobacteria in adult patients with cystic fibrosis. Chest.1992;

102:70–75.

155. Kim, T. C., N. S. Arora, T. K. Aldrich, and D. F. Rochester.

Atypical mycobacterial infections: a clinical study of 92 patients.

South. Med. J. 1981; 74:1304–1308.

156. Kirby, C., A. Waring, T. J. Griffin, J. O. Falkinham, 3rd, N. D.

Grindley, and K. M. Derbyshire. Cryptic plasmids of.

Mycobacterium avium: Tn552 to the rescue. Mol. Microbiol.

2002; 43:173–186.

157. Kline TS. Lymph nodes and superficial masses. In: Lotz JE, ed.

Handbook of fine needle aspiration cytology. St Louis: Mosby,

1981: 23-64.

158. Kobashi Y, Matsushima T. The microbiological and clinical

effects of combined therapy according to guidelines on the

treatment of pulmonary Mycobacterium avium complex disease

in Japan-including a follow-up study. Respiration.2007;74;394-

400.


190

159. Koch R, Die Aetiologie Der Tuberkulose, Berl Klin Wochenschr,

1882;19: 221-30.

160. Kohn MD, Altman KA. Jaundice due to rare causes: tuberculous

lymphadenitis. Am J Gastroenterol 1973; s59: 48-53.

161. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK. Clinical

significance of non-tuberculous mycobacteria isolated from

respiratory specimens in Korea. Chest. 2006;129: 341-8.

162. Korenromp EL, Scano F, Williams BG, Dye C, Nunn P. Effects of

human immunodeficiency virus infection on recurrence of

tuberculosis after rifampin-based treatment: an analytical

review. Clin Infect Dis 2003; 37 : 101-12.

163. Kirschner, P., M. Kiekenbeck, D. Meissner, J. Wolters, and E. C.

Bo¨ttger. Genetic heterogeneity within Mycobacterium fortuitum

complex species: genotypic criteria for identification. J. Clin.

Microbiol. 1992; 30:2772–2775.

164. Krishnaswamy H, Koshi G, Dash Sp. Tuberculous

lymphadenitis in South India – a histopathological and

bacteriological study 1972; 52: 215-220.

165. Kubica GP. Differential identification of mycobacteria. Am Rev

Resp Dis 1973; 107: 9-12.

166. Kumar A. Lymph node tuberculosis. In: Sharma SK,Mohan A,

editors. Tuberculosis. New Delhi: Jaypee Brothers Medical

Publishers; 2001 p. 273-84.


191

167. Kumar P, Sharma N, Sharma NC, Patnaik S. Clinical profile of

tuberculosis in patients with HIV Infection/AIDS. Indian J

Chest Dis Allied Sci 2002; 44: 159-63

168. Kusunoki, S., and T. Ezaki. Proposal of Mycobacterium

peregrinum sp. nov., nom. rev., and elevation of Mycobacterium

chelonae subsp. abscessus (Kubica et al.) to species status:

Mycobacterium abscessus comb. nov. Int. J. Syst. Bacteriol.

1992; 42:240–245.

169. Kwan LK, Stottmeier KD, Sherman IJ. Mycobacterial cervical

lymphadenopathy, relation of etiologic agents to age. JAMA

1984;251:1286-1288

170. Lado Lado FL, Barrio Gomez E, Carballo Arceo E, Cabarcos

Ortiz de Barron A. Clinical presentation of tuberculosis and the

degree of immunodeficiency in patients with HIV infection.

Scand J Infect Dis 1999;31: 387-91.

171. Laukkanen, H., H. Soini, S. Kontunen-Soppela, A. Hohtola, and

M. Viljanen. A mycobacterium isolated from tissue cultures of

mature Pinus sylvestris interferes with growth of Scots pine

seedlings. Tree Physiol. 2000; 20: 915–920.

172. Lau SK, Wei WI, Hsu C. Efficacy of fine needle aspiration

cytology in the diagnosis of tuberculous cervical

lymphadenopathy. J Laryngol Otol 1990; 104: 24-27.


192

173. Lazar, J., P. Nemet, R. Bracha, and A. Campus. Mycobacterium

fortuitum keratitis. Am. J. Ophthalmol. 1974;78:530–532.

174. Lee JH, Shine DH, Kang KW. The medical treatment of

tuberculous tracheo-esophageal fistula. Tuber Lung Dis 1992;

73: 177-179.

175. Lee KC, Tami TA, Lalwani AK. Contemporary management of

cervical tuberculosis. Laryngoscope 1992; 102: 60-64.

176. Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of

tuberculosis in HIV-infected patients. Respirology 2000; 5 : 423-

426.

177. Lehmann KB, Neumann R. 1896. Atlas und Grundis der

Bakteriologie und Lehrbuch der speciellen bakteriologischen

diagnositik, JF Lehmann, Munchen, Germany.

178. Lester, C.W. and Jones J.M.. American Review of Tuberculosis

and Pulmonary Diseases. 1956; 73: 329.

179. Levenson, D. S., and C. H. Harrison. Mycobacterium fortuitum

corneal ulcer. Arch. Ophthalmol. 1966;75:189–191.

180. Levin-Epstein AA, Lucente FE, Scrofula-the dangerous

masquerader. Laryngoscope 1982; 92: 938-943.

181. Levine, B., and R. E. Chaisson. Mycobacterium kansasii: a cause

of treatable pulmonary disease associated with advanced

human immunodeficiency virus (HIV) infection. Ann. Intern.

Med. 1991;114:861–868.


193

182. Levy-Frebault, V., F. Grimont, P. A. D. Grimont, and H. L.

David. Deoxyribonucleic acid relatedness study of the

Mycobacterium fortuitum- Mycobacterium chelonae complex. Int.

J. Syst. Bacteriol. 1986;36:458–460.

183. Lin Y, Zhang M, Hofman FM, Gong J, Barnes PF.Absence of a

prominent Th2 cytokine response in human tuberculosis. Infect

Immun 1996; 64:1351-6.

184. Llewelyn DM, Dorman D. Mycobacterial lymphadenitis. Aust

Paediatr J 1971;7:97-102.

185. Laidlaw M. In Mackie and McCartney’s practical medical

microbiology, 13th ed. London: Churchill Livingstone, 1989. p.

414.

186. Macchiarini P, Delamare N, Beuzeboc P. Tracheoesophageal

fistula caused by mycobacterial tuberculous adenopathy. Ann

Thorac Surg 1993; 55:1561-1563.

187. Mahadev, B., Kumar, P., Agarwal, S.P., Chauhan, L.S.,

Srikantaramu, N. Surveillance of drug resistance to anti

tuberculosis drugs in districts of Hoogli in West Bengal and

Mayurbhanj in Orissa. Indian J Tuberc. 2005; 52: 5-10.

188. Management of the adult Goroll AH, May LA, Mulley AG Jr.

Primary care medicine: office evaluation and patient. 2d ed.

Philadelphia: Lippincott, 1987.


194

189. Maniar, A. C., and L. R. Vanbuckethout. Mycobacterium

kansasii from an environmental source. Can. J. Public Health.

1976; 67:59–60.

190. Manolidis S, Frenkiel s, Yoskovitch A. Mycobacterial infections

of the head and neck. Otolaryngol Head Neck Surg 1993; 109:

427-433.

191. Mansfield, K. G., and A. A. Lackner. Simian immunodeficiency

virusinoculated macaques acquire Mycobacterium avium from

potable water during AIDS. J. Infect. Dis.1997; 175:184–187.

192. Marras TK, Chedore P, Ying AM, Jameson F. Isolation

prevalence of pulmonary non-tuberculous mycobacteria in

Ontario, 1997-2003. Thorax. 2007; 62:661-6.

193. Martin-Bates E, Tanner,A, Suvarna S K, Glazer G, Coleman D

V. Use of fine needle aspiration cytology for investigating

lymphadenopathy in HIV positive patients. J Clin Pathol 1993;

46: 564-566

194. McSwiggan, D. A., and C. H. Collins. The isolation of M. kansasii

and M. xenopi from water systems. Tubercle. 1974; 55:291–297.

195. Medical Research Council Cardiothoracic Epidemiology Group.

National survey of notifications of tuberculosis in England and

Wales in 1988. Thorax 1992; 47: 770-775.


195

196. Mert A, Tabak F, Ozaras R, Tahan V, Ozturk R, Aktuglu Y.

Tuberculous lymphadenopathy in adults: a review of 35 cases.

Acta Chir Belg 2002; 102: 118-121.

197. Miller, J.F.W. and Cashman, J.M. Lancet. 1958; 1: 286.

198. Miller R.H. Tuberculosis of Lymphatic System, MacMillan and

Co., New York. 1934;192.

199. Mohan A, Sharma SK. Epidemiology. In: Sharma SK, Mohan A,

editors. Tuberculosis. New Delhi: Jaypee Brothers Medical

Publishers; 2001 p.14-29.

200. Monie RDH, Hunter AM, Rocchiccioli KMS. Management of extra

pulmonary tuberculosis (excluding miliary and meningeal) in

South and West Wales (1976–78). BMJ 1982; 285: 415–8.

201. Murthy KJR, Frieden TR, Yazdani A, Hreshikesh P. Public

private partnership in tuberculosis control: experience in

Hyderabad, India. Int J Tuberc Lung Dis 2001; 5(4): 354-359.

202. Mushatt, D. M., and R. S. Witzig. Successful treatment of

Mycobacterium abscessus infections with multidrug regimens

containing clarithromycin.Clin. Infect. Dis. 1995;20:1441–1442.

203. Nataraj G, Kurup S, Pandit A, Mehta P. Correlation of fine

needle aspiration cytology, smear and culture in tuberculous

lymphadenitis: a Prospective study. Indian J Postgrad Med

2002; 48: 113-6.


196

204. Nohynek, L. J., M. H. Ha¨ggblom, N. J. Palleroni, K. Kronqvist,

E.-L. Nurmiaho-Lassila, and M. Salkinoja-Salonen.

Characterization of a Mycobacterium fortuitum strain capable of

degrading polychlorinated phenolic compounds. Syst. Appl.

Microbiol. 1993;16:126–134.

205. Norman A. Gross, Mario I. Mosunjac, Timothy M.Wallace. Utility

of fine needle aspiration in HIV-positive patients with

corresponding CD4 counts. Acta Cytol 1997; 3: 811-816.

206. Ohtake M, Saito H, Okuno M, Yamamoto S, Ohgimi T.

Esophagomediastinal fistula as a complication of tuberculous

mediastinal lymphadenitis. J Intern Med 1996; 35: 984-986.

207. Okumura M, Iwai K, Ogata H, Ueyama M, Kubota M, Aoki M.

clinical factors on cavitary and nodular bronchiectatic types in

pulmonary Mycobacterium avium complex disease. Intern Med.

2008;47:1465-72.

208. Olson RN. Nontuberculous mycobacterial infections of the face

and neck- practical considerations. Laryngoscope 1981; 91:

1714-1726.

209. Ord RF, Matz GJ, Tuberculous cervical lymphadenitis. Arch

Otolaryngol 1974;99:327-329.

210. Owens, M. W., G. T. Kinasewitz, and E. Gonzalez. Sandblaster’s

lung with mycobacterial infection. Am. J. Med. Sci. 1988;

295:554–557.


197

211. Pagel W, Simmonds FAH, Macdonald J, Nassan E. Pulmonary

tuberculosis. Fourth edition. London, Oxford University Press,

1964, p 245.

212. Pamra S P, Mathur G P. A Cooperative study of tuberculous

cervical lymphadenitis: Ind. J. Med. Res. 1974; 62: 11, 1631.

213. Pang Sc., Mycobacterial lymphadenitis in Western Australia.

Tubercle Lung Dis 1992; 73: 362-367.

214. Pang, Y., B. A. Brown, V. A. Steingrube, R. J. Wallace, Jr., and

M. C. Roberts. Tetracycline resistance determinants in

Mycobacterium and Streptomyces species. Antimicrob. Agents

Chemother. 1994; 38:1408–1412.

215. Paramasivan CN, Govindar D, Prabhakar R. Species level

identification of non tuberculous mycobacteria from South

Indian BCG trial area during 1981. Tubercle 1985; 66: 9-12.

216. Paramasivan CN, Herbert D, Prabhakar R. Non-tuberculous

mycobacteria: an overview. Lung India 1986; 4: 7-12.

217. Paredes C, Del Campo F, Zamarron C. Cardiac tamponade due

to tuberculous mediastinal lymphadenitis. Tubercle 1990; 71:

219-220.

218. Paull, A. An environmental study of the opportunist

mycobacteria. Med. Lab. Technol. 1973;30:11–19.

219. Pathak SK, Deshmukh PA, Menon CRN. A comparison of

different culture techniques. Indian J Tuberc 1973; 20: 85-7.


198

220. Paull, A. An environmental study of the opportunist

mycobacteria. Med. Lab. Technol. 1973; 30:11–19.

221. Peters, M., D. Schu¨rmann, A. C. Mayr, R. Hetzer, H. D. Pohle,

and B. Ruf. Immunosuppression and mycobacteria other than

Mycobacterium tuberculosis: results from patients with and

without HIV infection. Epidemiol. Infect. 1989;103:293–300.

222. Pezzia, W., J. W. Raleigh, M. C. Bailey, E. A. Toth, and J.

Silverblatt. Treatment of pulmonary disease due to

Mycobacterium kansasii: recent experience with rifampin. Rev.

Infect. Dis. 1981;3:1035–1039.

223. Picardeau, M., and V. Vincent. Mycobacterial linear plasmids

have an invertron-like structure related to other linear replicons

in actinomycetes. Microbiology. 1998; 144:1981–1988.

224. Pithie AD, Chicksen B. Fine needle extra-thoracic lymph node

aspiration in HIV-associated sputum negative tuberculosis.

Lancet 1992; 340: 1504-1505.

225. Pinner M. Atypical acid fast microorganisms. Am RevTuberc

1935; 32: 424-45.

226. Pitulle, C., M. Dorsch, J. Kazda, J. Wolters, and E.

Stackebrandt. Phylogeny of rapidly growing members of the

genus Mycobacterium. Int. J. Syst. Bacteriol. 1992; 42:337–343.


199

227. Poon RT, Lo CM, Fan St. Diagnosis and management of biliary

obstruction due to periportal tuberculous adenitis.

Hepatogastroenterology 2001;48:1585-1587.

228. Poprawski D, Pitisuttitum P, Tansuphasawadikul S. Clinical

presentations and outcomes of TB among HIV-positive patients.

Southeast Asian J Trop Med Public Health 2000; 31 (Suppl 1) :

140-2.

229. Portaels, F., Z. Kunze, J. J. McFadden, P. A. Fonteyne, and G.

Carpels. Mycobacterial diseases in AIDS patients from

developing and developed countries. Tegen Tuberculose. 1990;

2:67–71.

230. Portaels, F. 1973. Contribution a l’etude des mycobacteries des

l’environment au Bas-Zaire, p. 169–183. In Proceedings of the

3rd International olloquium on Mycobacteria. Prinz Leopold

Institute of Tropical Medicine, Antwerp, Belgium.

231. Powell DA. Tuberculous lymphadenitis. In: Schlossberg D,

editor. Tuberculosis and nontuberculous mycobacterial

infection. Philadelphia: W.B. Saunders Co; 1999 p. 186-94.

232. Prasanta RM, Ashok Kumar J. Tuberculous Lymphadenitis.

JAPI 2009;57:585-590.

233. Radhika S, Gupta SK. Role of culture for mycobacteria in fine-

needle aspiration diagnosis of tuberculous lymphadenitis. Diagn

Cytopathol 1989; 5: 260-262.


200

234. Ramakrishnan CV. Pulmonary disease due to atypical

mycobacteria: a retrospective study from South India. Rev Infect

Dis. 1981; 3 (5): 1090-2.

235. Ramond, L. Presse Med. 1936; 44: 1475.

236. Raviglione MC, Narain JP, Kochi A. HIV-associated tuberculosis

in developing countries: clinical features, diagnosis and

treatment. Bull World Health Organ 1992; 70 : 515-525.

237. Repath, F., J. H. Seabury, C. V. Sanders, and J. Domer.

Prosthetic valve endocarditis due to Mycobacterium chelonei.

South. Med. J. 1976; 69:1244–1246.

238. Report from the Medical Research Council Tuberculosis and

Chest Diseases Unit. National survey of tuberculosis

notifications in England and Wales in 1983: characteristics of

disease. Tubercle 1987;68:19-32.

239. Reported tuberculosis in the United States, 1999. Atlanta:

Centers for Disease Control and Prevention, August 2000.

240. Rich AR, ed. The Pathogenesis of tuberculosis. Springfield. II.:

Charles C Thomas Publisher, 1950.

241. Ristola, MA, von Reyn CF, Arbeit RD. High rates of

disseminated infection due to non-tuberculous mycobacteria

among AIDS patients in Finland. J Infect 1999; 39: 61–67.

242. RNTCP status report 2007. Central TB Divison Directorate

General of Health Services Ministry of Health and Family


201

Welfare Nirman Bhawan, New Delhi – 110011.

http://www.tbcindia.org

243. Roba-Kiewicz M, Grzybowski S. Epidemiologic aspects of non

tuberculous mycobacterial diseases and of tuberculosis in

British Columbia. Am Rev Respir Dis 1974; 109: 613-620.

244. Rober Stainbrook MD. Tuberculosis and HIV in India- The

challenges ahead. N Engl J Med.2007;356:1198-1199.

245. Robicsek, F., H. K. Daugherty, J. W. Cook, J. G. Selle, T. N.

Masters, P. R. O’Bar, C. R. Fernandez, C. U. Mauney, and D. M.

Calhoun. Mycobacterium fortuitum epidemics after open heart

surgery. J. Thorac. Cardiovasc. Surg. 1978;75:91–96.

246. Rogall, T., J. Wolters, T. Flohr, and E. C. Bottger. Toward a

phylogeny and definition of species at the molecular level within

the genus Mycobacterium. Int. J. Syst. Bacteriol. 1990; 40:323–

330.

247. Rom WN, Gray SM. Tuberculosis, 2nd edition, Lippincott

Williams & Wilkins 2004. p. 489-91.

248. Ross, B. C., K. Jackson, M. Yang, A. Sievers, and B. Dwyer.

Identification of a genetically distinct subspecies of

Mycobacterium kansasii. J.Clin. Microbiol. 1992; 30:2930–2933.

249. Ross, B. C., K. Raios, K. Jackson, and B. Dwyer. Molecular

cloning of a highly repeated DNA element from Mycobacterium

http://www.tbcindia.org/


202

tuberculosis and its use as an epidemiological tool. J. Clin.

Microbiol. 1992; 30:942–946.

250. Runyon EH. Anonymous mycobacteria in pulmonary disease,

Med Clin North Am. 1959; 43: 273-40.

251. Ryoo SW, Shin S, Shim MS, Park YS, Lew WJ, Park SN. Spread

of non-tuberculous mycobacteria from 1992 to 2006 in Koreans.

J Clin Lab Anal. 2008;22:415-20.

252. Safraneck, T. J., W. R. Jarvis, and L. A. Carson. Mycobacterium

chelonae wound infections after plastic surgery employing

contaminated gentian violet skin-marking solution. N. Engl. J.

Med. 1987; 317:197–201.

253. Sami Simons, Jakko van Ingen, Po-Ren Hsueh, Nguyen Van

Hung, P.N.Richard Dekhuijzen, Martin J.Boeree, Dic Van

Soolingen. Non tuberculous mycobacteria in respiratory tract

infection, Eastern Asia.EID.2011;17:343-349.

254. Saritsiri S, Udomsantisook N, suankratay C. Non-tuberculous

infection in King Chulalongkorn Memorial Hospital. J Med assoc

Thai. 2006;89:2035-46.

255. Schless, J.M. and Wier, J.A. American Review of Tuberculosis,

1957;76: 811.

256. Schluger NW, Rom WN. The host immune response to

tuberculosis. Am J Respir Crit Care Med 1998; 157: 679-691.


203

257. Schulze-Ro¨bbecke, R., and R. Fischeder. Mycobacteria in

biofilms. Zentralbl. Hyg. Unweltmed. 1989;188:385–390.

258. Selik, R. M., E. T. Starcher, and J. W. Curran. Opportunistic

disease reported in AIDS patients: frequencies, associations,

and trends. AIDS. 1987;1:175–182.

259. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH,

Klein RS. A prospective study of the risk of tuberculosis among

intravenous drug users with human immunodeficiency virus

infection. N Engl J Med 1989 ;320:545-550.

260. Shafer RW, Kim DS, Weiss JP, Quale JM. Extrapulmonary

tuberculosis in patients with human immunodeficiency virus

infection. Medicine (Baltimore) 1991;70: 384-397.

261. Sharma SK, Mohan A. Clinical manifestations. In: Sharma SK,

Mohan A, editors. Tuberculosis. New Delhi: Jaypee Brothers

Medical Publishers; 2001 p. 148-51.

262. Sharma SK, Mohan A, Gupta R, Kumar A, Gupta AK, Singhal

VK, et al. Clinical presentation of tuberculosis in patients with

AIDS: an Indian experience. Indian J Chest Dis Allied Sci 1997;

39: 213-220.

263. Sherer, R., R. Sable, M. Sonnenberg, S. Cooper, P. Spencer, S.

Schwimmer, F. Kocka, P. Muthuswamy, and C. Kallick.

Disseminated infection with Mycobacterium kansasii in the


204

acquired immunodeficiency syndrome. Ann. Intern. Med. 1986;

105:710–712.

264. Shu CC, Lee CH, Wang JY, Jerng JS, Yu CJ, Hsueh PR. Non-

tuberculous mycobacteria pulmonary infection in medical

intensive care unit: the incidence, patient characterisitics, and

clinical significance. Intensive Care Med.2008;34:2194-201.

265. Seidel, L., and C. Horhold. Selection and characterization of new

microorganisms for the manufacture of 9-OH-AD from sterols.

J. Basic Microbiol. 1992; 32:49–55.

266. Srikantam A, Moorthy K, Gokhale S. Bacteriological techniques

compliment the clinical and cytological diagnosis of tuberculosis

in human immuno deficiency virus infected persons. Indian J

Med Microbiol. 2006 Jul ;24(3):225-227.

267. Shikhani A, Hadi UM, Mufarrij AA. Mycobacterial cervical

lymphadenitis. Ear Nose Throat J 1989; 68: 660-672.

268. Siddiqui, M.A.H. Journal of Indian Medical Association, 1949;

19:9.

269. Simecek C. Diagnosis of mycobacterial mediastinal

lymphadenopathy by transbronchial needle aspiration (letter).

Chest 1992; 102: 1919.

270. Simpson, G. L., T. A. Raffin, and J. S. Remington. Association of

prior nocardiosis and subsequent occurrence of nontuberculous


205

mycobacteriosis in a defined, immunosuppressed population. J.

Infect. Dis. 1982; 146:211–219.

271. Singh B, Moodly M, Goga AD, Haffejee AA. Dysphagia secondary

to tuberculous lymphadenitis. S Afr J Surg 1996 ;34:197-199.

272. Siu KF, Ng A, Wong J. Tuberculous lymphadenopathy: a review

of results of surgical treatment. Aust Nz J Surg 1983;53:253-

257.

273. Sivasankari P, Annie B. Khyriem, K. Venkatesh, Subhash

Chandra Parija. Atypical mycobacterial infection among HIV

seronegative patients in Pondicherry. Indian J Chest Dis Allied

Sci. 2006; 48: 107-9.

274. Sjogren, I. Nontuberculous mycobacteria in Sweden: a brief

summary. Rev. Infect. Dis. 1981;3:1984.

275. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ,

Desmond E. Exogenous reinfection with multidrug-resistant

Mycobacterium tuberculosis in patients with advanced HIV

infection. N Engl J Med1993; 328 : 1137-44.

276. Smith, D., P. Reeser, and S. Musa. Does infection with

environmental mycobacteria suppress the protective response to

subsequent vaccination with BCG. Tubercle. 1985; 66:17–23.

277. Smith, M. J., J. Efthimiou, M. E. Hodson, and J. C. Batten.

Mycobacterial isolations in young adults with cystic fibrosis.

Thorax. 1984; 39:369–375.


206

278. Smith MJ, Grange JM. Deep tissue infections due to

environmental bacteria. In: Ratledge C, Stanford J, Grange MJ,

editors. Biology of mycobacteria, vol.3.London: Academic Press

Ltd; 1989 p. 511-64.

279. Snider DE, Onorato M. Epidemiology. In: Rossman MD,

MacGregor RR, editors. Tuberculosis: clinical management and

new challenges. New York: McGraw-Hill; 1995 p. 3-17.

280. Soriano E, Mallolas J, Gatell JM. Characteristics of tuberculosis

in HIV-infected patients; a case-control study. AIDS

1988;2:429-432.

281. Subrahmanyam M. Role of surgery and chemotherapy for

peripheral lymph node tuberculosis. Br J Surg 1993; 8: 1547-8.

282. Subramanian S, Mazumder PR, Vijaya S. Tuberculosis of the

intercostals lymph nodes: an unusual presentation. Tubercle

1974;55: 163-166.

283. Suwankrughasn, N., and J. L. Leat. Artificial colonization as a

method for studying the normal habitat of mycobacteria.

Tubercle. 1977; 58:25–27.

284. Stanley BR, Fernandez AJ, Peppard BS. Cervicofacial

mycobacterial infections presenting as major salivary gland

disease. Laryngoscope 1983; 93: 1271-1275.


207

285. Stahl, D. A., and J. W. Urbance. The division between fast- and

slow-growing species corresponds to natural relationships

among the mycobacteria. J. Bacteriol. 1990;172:116–124.

286. Steadham, J. E. High catalase Mycobacterium kansasii isolated

from water in Texas. J. Clin. Microbiol. 1980;11:496–498.

287. Stoneburner RL., Tuberculosis and acquired immunodeficiency

syndrome – New York City. JAMA 1988;259:338-340.

288. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of

the situation today. Bull World Health Organ 1992; 70:149–159.

289. Suwankrughasn, N., and J. L. Leat. Artificial colonization as a

method for studying the normal habitat of mycobacteria.

Tubercle. 1977; 58:25–27.

290. Swenson, J. M., R. J. Wallace, Jr., V. A. Silcox, and C.

Thornsberry. Antimicrobial susceptibility testing of five

subgroups of Mycobacterium fortuitum and Mycobacterium

chelonae. Antimicrob. Agents Chemother. 1985; 28: 807–811.

291. Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW,

Chaisson RE. Human immunodeficiency virus infection in

tuberculosis patients. J Infect Dis 1990; 162 : 8-12.

292. Thompson MM, Underwood MJ, Sayers RD, Dookeran KA, Bell

PRF. Peripheral tuberculous lymphadenopathy: a review of 67

cases. Br J Surg 1992; 79: 763-764.

293. Thompson, B.C. (1940). Tubercle, 21, 217.


208

294. Timpe A, Runyon EH. The relationship of “atypical” acid-fast

bacteria to human disease: a preliminary report. J Lab Clin Med

1954;44:202-209.

295. Tisseuil, J. (1946). Bull. Soc. Path. Exot. ,49, 343.

296. Tortoli, E., A. Bartoloni, E. C. Bottger, S. Emler, C. Garzelli, E.

Magliano, A. Mantella, N. Rastogi, L. Rindi, C. Scarparo, and P.

Urbano. Burden of unidentifiable mycobacteria in a reference

laboratory. J. Clin. Microbiol. 2001;39:4058–4065.

297. Tsukamura, M., H. Shimoide, N. Kita, K. Kawakami, T. Ito, N.

Nakajima, H. Kondo, Y. Yamamoto, N. Matsuda, M. Tamura, K.

Yoshimoto, N. Shirota, and A. Kuse. Epidemiologic studies of

lung disease due to mycobacteria other than Mycobacterium

tuberculosis in Japan. Rev. Infect. Dis. 1981;3:997–1007.

298. Tsukamura, M., N. Kita, H. Shimoide, H. Arawaka, and A. Kuze.

Studies on the epidemiology of nontuberculous mycobacteriosis

in Japan. Am. Rev. Respir. Dis. 1988; 137:1280–1284.

299. Tsukamura, M., H. Shimoide, N. Kita, K. Kawakami, T. Ito, N.

Nakajima, H. Kondo, Y. Yamamoto, N. Matsuda, M. Tamura, K.

Yoshimoto, N. Shirota, and A. Kuse. Epidemiologic studies of

lung disease due to mycobacteria other than Mycobacterium

tuberculosis in Japan. Rev. Infect. Dis. 1981; 3:997–1007.

300. Uotila, J. S., V. H. Kitunen, T. Saastamoinen, T. Coote, M. M.

Ha¨ggblom, and M. S. Salkinoja-Salonen. Characterization of


209

aromatic ehalogenases of Mycobacterium fortuitum CG-2. J.

Bacteriol. 1992; 174:5669–5675.

301. Van Ingen J, Bendien SA, de Lange WC, Hoefsloot W,

Dekhuijzen PN, Boeree MJ. Clinical relevance of non-

tuberculous mycobacteria isolated in the Nijmegen-Arnhem

region, the Netherlands. Thorax. 2009; 64:502-

6:10.1136/thrx.2008.110957.

302. Van Ingen J, Boeree MJ, Kosters K, Wieland A, Tortoli E,

Dekhuijzen PN. Proposal to elevate Mycobacterium avium

complex ITS sequevar MAC-Q to Mycobacterium vulneris sp.

Nov. Int J Syst Evol Microbiol. 2009;59:2277-82.

303. Vennera MC, Moreno R, Cot J, Marin A, Sanchez-Lloret J,

Picado C. Chylothorax and tuberculosis. Thorax 1983;38:694-5.

304. Verenkar M P, Kavitha Kamath, Pinto W M J, Rodrigues S,

Wiseman Pinto R G. Mycobacteriological study of Fine Needle

Aspirates in Cervical Lymphadenitis. Indian J Tuberc 1996; 43:

187.

305. Viallier, J. 1973. Les mycobacte´ries atypiques du milieu

hydrotelluriques, p. 167–176. In 98th Congress of the Nat.

Societes Savantes St. Etienne, vol. 1.

306. von Reyn, C. F., R. D. Arbeit, C. R. Horsburgh, M. A. Ristola, R.

D. Waddell, S. M. Tvaroha, M. Samore, L. R. Hirschhorn, J.


210

Lumio, A. D. Lein, and M. R. Grove. Sources of disseminated

Mycobacterium avium infection in AIDS. J. Infect. 2002;44:166

307. von Reyn, C. F., R. D. Waddell, T. Eaton, R. D. Arbeit, J. N.

Maslow, T. W. Barber, R. J. Brindle, C. F. Gilks, J. Lumio, J.

Lahdevirta. Isolation of Mycobacterium avium complex from

water in the United States, Finland, Zaire, and Kenya. J. Clin.

Microbiol. 1993;31:3227–3230.

308. Vorbrodt, H.-M., G. Adam, A. Porzel, C. Hohold, S. Danhardt,

and K.-H. Bohme. Microbial degradation of 2a,3a-dihydroxy-5a-

cholestan-6-one by Mycobacterium vaccae. Steroids. 1991;

56:586–588.

309. Young JEM, Archibald SD, Shier KJ. Needle aspiration cytologic

biopsy in head and neck masses. Am J Surg 1981;142: 484-

489.

310. Wallace, R. J., Jr. Recent changes in taxonomy and disease

manifestations of the rapidly growing mycobacteria. Eur. J.

Clin. Microbiol. Infect. Dis. 1994; 13:953–960.

311. Wackett, L. P., G. A. Brusseau, S. R. Householder, and R. S.

Hanson. Survey of microbial oxygenases: trichloroethylene

degradation by ropaneoxidizing bacteria. Appl. Environ.

Microbiol. 1989;55:2960–2964.


211

312. Wallace RJ Jr, O’Brein R, Glassroth J, Raleigh J, Dutta A.

Diagnosis and treatment of disease caused by nontuberculous

mycobacteria. Am Rev Respir Dis 1990;142 : 940-953.

313. (a)Wallace, R. J., Jr., L. C. Steele, A. Labidi, and V. A. Silcox.

Heterogeneity among isolates of rapidly growing mycobacteria

responsible for infections following augmentation mammaplasty

despite case clustering in Texas and other southern coastal

states. J. Infect. Dis. 1989; 160:281–288.

314. Wallace, R. J., Jr., B. A. Brown, and G. O. Onyi. Skin, soft

tissue, and bone infections due to Mycobacterium chelonae

chelonae: importance of prior corticosteroid therapy, frequency

of disseminated infections, and resistance to oral antimicrobials

other than clarithromycin. J. Infect. Dis. 1992; 166:405–412.

315. Wallace, R. J., Jr., J. M. Musser, S. I. Hull, W. A. Silcox, L. C.

Steele, G. D. Forrester, A. Labidi, and R. K. Selander. Diversity

and sources of rapidly growing mycobacteria associated with

infections following cardiac surgery. J. Infect. Dis. 1989;

159:708–716.

316. Wallace, R. J., Jr., J. M. Swenson, V. A. Silcox, R. C. Good, J. A.

Tschen, and M. Seabury Stone. Spectrum of disease due to

rapidly growing mycobacteria. Rev. Infect. Dis. 1983; 5:657–

679.


212

317. Wayne LG, Sramek HA. Agents of newly recognized or

infrequently encountered mycobacterial diseases. Clin Microbiol

Rev 1992; 5 : 1-25.

318. Weiler Z, Nelly P, Baruchin AM. Diagnosis and treatment of

cervical tuberculous lymphadenitis. J Oral Maxillofac Surg

2000; 58: 477-481.

319. Weimin L, Guanglu J, Zhihui L, Huakan H, Liquan C, Miao T.

Non-tuberculous mycobacteria in China. Scand J Infect Dis.

2007;39:138-401.

320. Weir MR, Thorton GF. Extrapulmonary tuberculosis. Experience

of a community hospital and review of the literature. Am J Med

1985; 79: 467-476.

321. Willis, W. E., and P. R. Laibson. Intractable Mycobacterium

fortuitum corneal ulcer in man. Am. J. Ophthalmol.

1971;71:500–504.

322. Wilson RS, White RJ. Lymph node tuberculosis presenting as

chyluria. Throax 1976;31: 617-620.

323. Wilmot, T.J., James, E.F. and Reilly, L.V. Lancet. 1957; 2: 1184.

324. Witht.Vielh. The techniques of FNA cytology. In: Orell S R,

Sterett F G, Walters M N, Whitaker D, eds. Manual and Atlas of

Fine Needle Aspiration Cytology. NY, USA: Churchill

Livingstone, 1999: pp 10-27.


213

325. Witzig, R. S., B. A. Fazal, R. M. Mera, D. M. Mushatt, P. M. J. T.

Dejace, D. L. Greer, and N. E. Hyslop, Jr. Clinical

manifestations and implications of coinfection with

Mycobacterium kansasii and human immunodeficiency virus

type 1. Clin. Infect. Dis. 1995; 21:77–85.

326. Wolinsky E. Nontuberculous mycobacteria and associated

disease. Am Rev Respir Dis 1979; 119 : 107-159.

327. Wolinsky, E., and T. K. Rynearson. Mycobacteria in soil and

their relation to disease-associated strains. Am. Rev. Respir.

Dis. 1968; 97:1032–1037.

328. Wong ML, Jafek BW. Cervical mycobacterial disease. Trans Am

Acad Ophthalmol Otolaryngol. 1974; 78: 75-87.

329. Wright, E. L., S. Zywno-van Ginkel, N. Rastogi, and W. W.

Barrow. Monoclonal infection involving Mycobacterium avium

presenting with three distinct colony morphotypes. J. Clin.

Microbiol. 1996; 34:2475–2478.

330. Wunsh, S. E., G. L. Boyle, I. H. Leopold, and M. L. Littman.

Mycobacterium fortuitum infection of corneal graft. Arch.

Ophthalmol. 1969; 82:602–607.

331. Yamamoto M, Sudo K, Taga M. A study of disease caused by

atypical mycobacteria in Japan. Am Rev Respir Dis 1967;96:

779-787.


214

332. Yates MD, Grange JM. Bacteriological survey of tuberculous

lymphadenitis in Southeast England. 1981-1989. J Epidemiol

commun Health 1992; 46:332-335.

333. Yates, M. D., J. M. Grange, and C. H. Collins. The nature of

mycobacterial disease in south east England, 1977–84. J.

Epidemiol. Community Health. 1986; 40:295–300.

334. Yates, M. D., A. Pozniak, and J. M. Grange. Isolation of

mycobacteria from patients seropositive for the human

immunodeficiency virus (HIV) in south east England: 1984–

1992. Thorax. 1993; 48:990–995.

335. Yew, W.-W., P.-C. Wong, H.-S. Woo, C.-W. Yip, C.-Y. Chan, and

F.-B. Cheng. Characterization of Mycobacterium fortuitum

isolates from sternotomy wounds by antimicrobial

susceptibilities, plasmid profiles, and ribosomal ribonucleic acid

gene restriction patterns. Diagn. Microbiol. Infect. Dis.

1993;17:111–117.

336. Yim JJ, Kim HJ, Kwon OJ, Koh WJ. Association between

microsatellite polymorphisms in intron II of the human Toll like

receptor 2 gene and non tuberculous mycobacterial lung disease

in Korean population. Human Immunol. 2008;69:572-6.

337. Zakowski, P., S. Fligiel, G. W. Berlin, and L. Johnson, Jr.

Disseminated Mycobacterium avium-intracellulare infection in


215

homosexual men dying of acquired immunodeficiency. JAMA.

1982; 248:2980–2982.

338. Zeligman I. Mycobacterium marinum granuloma. A disease

acquired in the tributaries of Chesapeake Bay. Arch Dermatol

1972; 106: 26-31.

339. Zimmerman, L. E., L. Turner, and J. W. McTigue.

Mycobacterium fortuitum corneal ulcer. Arch. Ophthalmol. 1969;

82:596–601.

340. Zopf W, Die Spaltpilze, Edward Trewendt, Breslau. Zumla AI.

Grange J. Non-tuberculous mycobacterial pulmonary infections.

Clin. Chest Med. 2002; 23: 369–76.

bibliography - shodhgangashodhganga.inflibnet.ac.in/bitstream/10603/8380/16/16...kansasii or...

Documents